Female Sexual Dysfunction Induced by Second-Generation Antipsychotic Drugs—A Disproportionality Analysis Based on the FAERS Database
This pharmacovigilance study highlights significant associations between specific SGAs and female sexual dysfunction. Disproportionality signals vary by drug, symptom type, and prolactin-related mechanisms. Clinicians should consider sexual side effects in treatment decisions and monitor patients accordingly. Further prospective studies are warranted.
Authors
- Dongdong Wang (ORCID: https://orcid.org/0000-0001-9956-6861)
- Liuyin Jin
- Linman Wu
- Yu Cao
Institutions
- North Sichuan Medical University (CN)
- Ningbo No. 2 Hospital (CN)
- Lishui City People's Hospital (CN)
- Baoshan University (CN)
- Nanchong Central Hospital (CN)
Publication Details
- Journal
- Schizophrenia Bulletin
- Published
- 2025-11-24
- DOI
- https://doi.org/10.1093/schbul/sbaf221
- Primary Topic
- Sexual function and dysfunction studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00